(Approval lapsed) ERGONOVINE MALEATE INJECTION (Ergonovine Maleate Injection, USP) 0.25 mg/mL, 1 mL ampoules
Section 19A approved medicine
(Approval lapsed) ERGONOVINE MALEATE INJECTION (Ergonovine Maleate Injection, USP) 0.25 mg/mL, 1 mL ampoules
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 516
Phone
1800 181 060
Approved until
Status
Expired
Medicines in short supply/unavailable
DBL ERGOMETRINE INJECTION Ergometrine maleate injection - ARTG 58866
Indication(s)
Prevention or treatment of postpartum or post-abortal hemorrhage due to uterine atony.
Additional information
Please note:
- The active ingredient ergometrine maleate is known as ergonovine maleate overseas.
- The Australian registered product has a different concentration to the overseas product. Health professionals should take care when using Ergonovine maleate injection USP (0.25 mg/mL) ampoule to ensure the correct dosage is used.
- The safety advisory statement for Ergometrine injection and its alternative under section 19A may be found at: https://www.tga.gov.au/alert/ergometrine-maleate-injection-500-microgra…